baltimore asthma intervention trial

30
Baltimore Asthma Intervention Trial Patrick N. Breysse, PhD Professor and Director Division of Environmental Health Engineering Department of Environmental Health Sciences Johns Hopkins Bloomberg School of Public Health Associate Director Center for Childhood Asthma in the Urban Environment

Upload: ronan-tyson

Post on 30-Dec-2015

34 views

Category:

Documents


0 download

DESCRIPTION

Baltimore Asthma Intervention Trial. Patrick N. Breysse, PhD Professor and Director Division of Environmental Health Engineering Department of Environmental Health Sciences Johns Hopkins Bloomberg School of Public Health Associate Director - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Baltimore Asthma Intervention Trial

Baltimore Asthma Intervention Trial

Patrick N. Breysse, PhDProfessor and Director Division of Environmental Health

EngineeringDepartment of Environmental Health Sciences

Johns Hopkins Bloomberg School of Public Health

Associate DirectorCenter for Childhood Asthma in the Urban Environment

Page 2: Baltimore Asthma Intervention Trial

Centers for Children’s Environmental Health

Co sponsored by NIEHS, EPA, CDC

Page 3: Baltimore Asthma Intervention Trial

Johns Hopkins Center for the Asthmatic Child in the Urban

Environment (CCAUE)

Director: Peyton A. Eggleston, MD Associate Director: Patrick Breysse, PhD

Tim Buckley, PhD

Gregory Diette, MD, MS

Sukon Kanchanaraska, PhD

Jerry Krishnan, MD

Elizabeth Matsui, MD

Sekhar Reddy, PhD

Arlene Butz, RN, DSc

Cynthia Rand, PhD

Marsha Wills-Karp, PhD

Steve Georas, MD

Investigators

Page 4: Baltimore Asthma Intervention Trial

Why Focus on Asthma?

• In 1999…– 10,488,000 persons with asthma in US (3.8%)– 14.5 million work days lost with asthma– 3,114,000 children < 14 yrs old with asthma (4.9%)– 14 million lost school days– 14.6% report activity limited by asthma– 10,808,000 physician visits– 1,997,000 ER visits for acute asthma– 478,000 hospitalizations for asthma– 4657 deaths

CDC MMWR March 29, 2002 / 51(SS01);1-13

Page 5: Baltimore Asthma Intervention Trial

CCAUE

• Multidisciplinary research center

• Combine basic research and community based studies

• Long Term Goals– Understand mechanism by which allergens,

pollutant increases airway inflammation and asthma morbidity

– Develop effective intervention strategies

Page 6: Baltimore Asthma Intervention Trial

Environmental Factors in Urban Asthma Research Model

RESPIRATORYMORBIDITY

SUSCEPTIBILITY FACTORSATOPY, INFLAMMATION CONTROL

BRONCHIAL HYPERRESPONSIVENESS

ASTHMATICAIRWAY

OBSTRUCTION

AIR POLLUTANTS

ALLERGENS

CHILDREN LIVINGIN URBAN

ENVIRONMENTS

UNDERLYING SOCIAL SUSCEPTIBILITY FACTORS POVERTY, STRESS, CONFLICTING NEEDS, EDUCATION, ADHERENCE, ACCESS TO CARE

IMMUNOLOGIC SENSITIZATION

Page 7: Baltimore Asthma Intervention Trial

CCAUE Study Components

• Community Based Studies– Cohort Study of Environmental Asthma

• Longitudinal comparison of environmental exposures and other risk factors

• Greg Diette et al.

– Asthma Susceptibility to Particulates, Allergens • Genetic association of environmental exposures and asthma• Greg Diette et al.

– Asthma Intervention Trial• Randomized trial to reduced household exposures to

particulate matter and allergens• Peyton Eggleston et al.

Page 8: Baltimore Asthma Intervention Trial

CCAUE Study Components

• Basic Biologic Research– Genetics of Response to Ozone

• Mouse model examining genetic basis of Ozone and endotoxin inflammation

• Sekhar Reddy, Steve Kleeberger– Inflammatory Response to Particulate Matter

• Mouse model comparing susceptible and non-susceptible strains

• Compare indoor and outdoor particulate matter• Marsha Wills-Karp

– Dendritic Cell Response to Particulate Matter• In vitro response of cultured dendritic cells• Steve Georas

Page 9: Baltimore Asthma Intervention Trial

CCAUE Community Outreach

• Community Advisory Committee– 9 members representing political

organizations, schools, churches, parents

• Advisory Functions– Protocol feasibility– Community priorities, concerns– Translation of results to local community

Page 10: Baltimore Asthma Intervention Trial

387 children enrolled in asthma education

program

180 eligible andinterested

13 ineligible 42 refused or unable to contact

125 consented, questionnaire completed

116 baseline home evaluation

100 randomized

97 competed 1 year study

6 refused or unable to contact

16 failed scheduled visits3 moved out of area

3 dropped out of study

93 ineligible44 refused

Recruitment

Page 11: Baltimore Asthma Intervention Trial

CCAUE – Asthma Intervention Study

• Randomized Controlled Trial of Home Exposure Control in Asthma

• Rationale– Strong epidemiologic evidence that indoor

environmental exposure relates to asthma morbidity– Effective treatments available for indoor

environmental exposure • Goal

– Test hypothesis that reduction of allergen and pollutant exposure in the homes of asthmatic children will reduce morbidity

Page 12: Baltimore Asthma Intervention Trial

STUDY AREA

Air monitoring station

Page 13: Baltimore Asthma Intervention Trial
Page 14: Baltimore Asthma Intervention Trial

Recruitment Plan

• 100 children recruited from elementary schools in inner city neighborhoods

• Eligibility:

– 6 – 12 years old– Doctor-diagnosed asthma– Current asthma symptoms – No other lung disease – Live in catchment area

Page 15: Baltimore Asthma Intervention Trial

Intervention Protocol

questionnaireskin test

serum,FEV1

home environment

telephone

0 3 6 9 12

BASELINE

CONTROL

TREATMENT

TREATMENT

INTERVENTION

Page 16: Baltimore Asthma Intervention Trial

Intervention

• 3-4 home visits by home health educators

• Roach extermination, sealed plastic containers

• Allergen-proof bedding encasings

• HEPA air cleaner in child’s bedroom

• Smoking cessation education and support

Page 17: Baltimore Asthma Intervention Trial

Air Cleaner

Page 18: Baltimore Asthma Intervention Trial

Environmental Monitoring

• Indoor Air Pollutants were measured over a 72-hr period in child's bedroom– Particulate Matter

• PM10

• PM2.5

• Data-logging Nephelometer

– Ozone– Nitrogen Dioxide– Airborne nicotine (marker for passive smoking

exposure)

Page 19: Baltimore Asthma Intervention Trial

In-Home Air Sampling Set-Up

Page 20: Baltimore Asthma Intervention Trial

0

0.2

0.4

0.6

0.8

1

1.2

1.4 1

6:34

:30

18:

21:3

0

20:

08:3

0

21:

55:3

0

23:

42:3

0

01:

29:3

0

03:

16:3

0

05:

03:3

0

06:

50:3

0

08:

37:3

0

10:

24:3

0

12:

11:3

0

13:

58:3

0

15:

45:3

0

17:

32:3

0

19:

19:3

0

21:

06:3

0

22:

53:3

0

00:

40:3

0

02:

27:3

0

04:

14:3

0

06:

01:3

0

07:

48:3

0

09:

35:3

0

11:

22:3

0

13:

09:3

0

14:

56:3

0

16:

43:3

0

18:

30:3

0

20:

17:3

0

22:

04:3

0

23:

51:3

0

PM

Co

nc

(mg

/m3)

Outdoor

Indoor

Central Site

Comparison of Indoor, Outdoor at the Home, and Outdoor Central Site Particulate Matter

Page 21: Baltimore Asthma Intervention Trial

Reservoir Dust Allergen Samples

• Vacuum samples collected in bedroom, living room/family room, and kitchen– Analyzed for

• Cockroach• Dust mite• Cat• Dog• Mouse

Page 22: Baltimore Asthma Intervention Trial

Baseline Characteristics

CONTROL TREATMENT

Age (mean) 8.3 8.5

home ETS (%) 65 73

Cockroach (%) 66 62

Pos skin test (%) 65 75

Mod/severe syx (%) 20 28

controller meds (%) 34 28

FEV1 (% pred) 94±21 101±20

ED visit/3 mon (%) 36 32

Page 23: Baltimore Asthma Intervention Trial

Housing CharacteristicsCharacteristic % Characteristic %Row House 91 Leaks in bedroom 18

Roof Leaks 24 Food in bedroom 29

Cats 26 Cockroaches in bedroom 8

Dogs 20 Mouse droppings in bedroom

7

Current smoker 46

Moisture damage in kitchen 22

Cockroaches in kitchen 31

Mouse droppings in kitchen 38

Page 24: Baltimore Asthma Intervention Trial

0

10

20

30

40

50

60

baseline 6 mon 12 mon

Median Particulate Concentrations

g/m3(median)

PM10 treatment PM 2.5 treatment PM 10 control PM 2.5 control

Page 25: Baltimore Asthma Intervention Trial

-50

-40

-30

-20

-10

0

10

20

baseline 6 months 12 months

% c

ha

ng

e f

rom

ba

se

lin

e

PM10 treatment PM 2.5 treatment PM 10 control PM 2.5 control

p<0.001

p<0.001

p=0.08

p=0.019

Particulate Concentrations:% Change

PM10 treatment PM 2.5 treatment PM 10 control PM 2.5 control

Page 26: Baltimore Asthma Intervention Trial

Bedroom Cockroach Allergen

1

10

base 6 mon 12 mon

Bla g 1U/gm

p=0.07p=0.001

TreatmentControl

Page 27: Baltimore Asthma Intervention Trial

Proportion of children with wheeze, cough, dyspnea in last 2 weeks

-40

-30

-20

-10

0

10

20

30

40

base 3 mon 6 mon 9 mon 12 monCh

ang

e in

pro

po

rtio

n w

ith

sym

pto

ms

Treatment group

Control group

p=<0.001

p=0.60p=<0.001 p=0.02

Page 28: Baltimore Asthma Intervention Trial

Other Health Outcomes

• Other health outcomes not different between the two groups– Nighttime symptoms– ED visits– Hospitalizations

– FEV1

Page 29: Baltimore Asthma Intervention Trial

Summary

• A global environmental intervention was able to reduce levels of PM10, PM2.5 and cockroach allergen in inner city homes

• There was an associated reduction in symptoms in asthmatic children living in the homes

• Persistence of reduction is uncertain

Page 30: Baltimore Asthma Intervention Trial

Acknowledgements

• In addition the investigators previously mentioned– Chris Beck - Nowella Durkin– D’Ann Williams - Mayme Grant– Jean Curtin-Brosnan - Craig Lewis – Lee Swartz - Jennette

Logan– Barry Merriman - Zina Nettles-Smith – Karen Callahan - Dena Scott